All
FDA Approves Erleada for Nonmetastatic Castration-Resistant Prostate Cancer
February 15th 2018The Food and Drug Administration (FDA) approved Erleada (apalutamide) for the treatment of patients who have nonmetastatic castration-resistant prostate cancer (CRPC). The drug is now the first FDA-approved treatment in this setting.
Cancer Survivors and Olympians: Are They Really So Different?
February 14th 2018Yes, I have a great admiration for the Olympic athletes who fall and get right back up. I know they have to wait another four years. But the cancer survivors I have met on my journey who fall and rebound are real heroes to me.
'Obesity Paradox' Offers Puzzling Survival Advantage in Men with Metastatic Melanoma
February 14th 2018While obesity is a known risk factor for more than a dozen types of cancer – and poised to take over smoking as the leading preventable cause for the disease – it may actually play a beneficial role in men with metastatic melanoma, according to a recent study published in Lancet Oncology.
Efficacy Offsets High Costs for Immunotherapy in US, But Not Overseas
February 14th 2018Researchers from Israel, the United Kingdom (UK) and Canada sought to determine the cost-effectiveness of Keytruda for the second-line treatment of patients with advanced bladder cancer. Drug costs were compared between the US, UK, Canada and Australia.
Examining PARP Inhibitors in the Maintenance Setting of Ovarian Cancer
February 13th 2018PARP inhibitors have drastically changed the treatment landscape – and outcomes – of patients with ovarian cancer. However, despite promise shown among this class of drugs, it is still unclear which agent is the best to use in the maintenance setting.
Physical Therapy Helps Women Recover Arm Mobility After Lymph Node Surgery
February 13th 2018“Our take home message here is that all women receiving lymph node dissection, whether it is axillary or sentinel, should receive physical therapy to regain range of motion more quickly after surgery, and thus, help maintain physical functioning,” said Electra D. Paskett, Ph.D., MO.
Exercise Has Short- and Long-Term Benefits for Cancer Survivors
February 13th 2018Fatigue is a life-altering and often long-lasting effect that impacts many cancer survivors. And while there is currently no cure for the condition, recent research presented at the 2018 Cancer Survivorship Symposium found that exercise can have both short- and long-term benefits for patients dealing with fatigue.
FDA Grants Lorlatinib a Priority Review for Lung Cancer Treatment
February 13th 2018Lorlatinib was granted a priority review to a new drug application (NDA) for patients with ALK-positive metastatic non–small cell lung cancer (NSCLC) who have progressed on one or more ALK tyrosine kinases inhibitors (TKIs).
Type of Health Insurance and Marital Status Affect Outcomes in Liver Cancer
February 12th 2018People treated for liver cancer at an inner-city hospital experienced better survival odds if they had private health insurance, and also if they were married, according to the results of a recent study that considered how socioeconomic factors affect health outcomes for those with the disease.
Barbells for Boobs Strengthens the Fight Against Breast Cancer
February 12th 2018The mission of Barbells for Boobs is to mobilize and empower people to take action against breast cancer. The organization will help people – of all ages, and regardless of insurance status or type – to get screened by connecting them with resources in their area.
Survey Reveals Impairment in Sexual Function Among Germ-Cell Tumor Survivors
February 9th 2018Germ cell tumors are growths that form from reproductive cells, which can be malignant or benign. In men, these tumors typically form in the testicles. The plus side is these tumors tend to respond well to treatment, even when diagnosed at later stages. However, one problem still persists after a cure.